Your browser doesn't support javascript.
loading
External quality control program in screening for infectious diseases at blood banks in Mexico.
Bello-López, J Manuel; Castañeda-García, Cristina; Muñoz-Estrada, Celerino; Machorro-Peréz, Antonio José.
Afiliação
  • Bello-López JM; Centro Nacional de la Transfusión Sanguínea, Av. Othón de Mendizábal 195, Zacatenco, Gustavo A. Madero, 07360, Mexico City, Mexico; Research Unit in Microbiology and Toxicology, Hospital Juárez de México, Av. Instituto Politécnico Nacional 5160, Zacatenco, Gustavo A. Madero, 07360, Mexico City, Mexi
  • Castañeda-García C; Centro Nacional de la Transfusión Sanguínea, Av. Othón de Mendizábal 195, Zacatenco, Gustavo A. Madero, 07360, Mexico City, Mexico.
  • Muñoz-Estrada C; Centro Nacional de la Transfusión Sanguínea, Av. Othón de Mendizábal 195, Zacatenco, Gustavo A. Madero, 07360, Mexico City, Mexico.
  • Machorro-Peréz AJ; Centro Nacional de la Transfusión Sanguínea, Av. Othón de Mendizábal 195, Zacatenco, Gustavo A. Madero, 07360, Mexico City, Mexico.
Transfus Apher Sci ; 57(1): 97-101, 2018 Feb.
Article em En | MEDLINE | ID: mdl-29452838
INTRODUCTION: Quality control for the detection of infectious markers in blood banks is a necessary activity to ensure the accuracy of donor screening results. Considering that in Mexico blood safety is one of the goals of the National Action Programs, it is essential to evaluate banks through an External Quality Control Program. OBJECTIVE: To analyze one of the evaluations that showed the greatest participation (2014-2/lot46) of banks in the Mexican Republic in the detection of transfusion-transmitted diseases. MATERIALS AND METHODS: A randomized panel of infectious markers of HIV, HCV, HBV, Treponema pallidum and Trypanosoma cruzi was manufactured under high quality standards. The evaluation criteria for each infectious marker were the identification of false positives and false negative results. Additionally, technologies used to detect infectious markers were requested for each bank. RESULTS: Of the 503 banks, only 374 participated in the evaluation. Technologies based on chemiluminescence, immunofluorescence and immunocolorimetry were used to detect viral markers. Even rapid tests for T. pallidum continue to be the methods of choice with 42%. Trypanosoma cruzi was 20% with fast techniques versus 80% with automated tests. Highest incidence of false positives was identified for T. pallidum and HBV, followed by T. cruzi, HIV and HCV. Fourteen (3.74%) false negatives results were identified for T. cruzi, followed by T. pallidum (n = 5/1.33%), HCV (n = 4/1.06) and HVB/HIV (n = 2/0.53%). CONCLUSION: False positive results identified for each infectious marker was considered high. This evidence will allow us to focus on areas of opportunity during serologic screening with greater emphasis on good laboratory practices.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bancos de Sangue / Segurança do Sangue / Armazenamento de Sangue / Infecções Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Limite: Female / Humans / Male País/Região como assunto: Mexico Idioma: En Revista: Transfus Apher Sci Assunto da revista: HEMATOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bancos de Sangue / Segurança do Sangue / Armazenamento de Sangue / Infecções Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Limite: Female / Humans / Male País/Região como assunto: Mexico Idioma: En Revista: Transfus Apher Sci Assunto da revista: HEMATOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de publicação: Reino Unido